Imatinib for treating patients with chronic myelogeneous leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib for treating patients with chronic myelogeneous leukemia

Published:2015-10-30 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Navas Vinicio¹,Simancas-Racines Daniel¹,González Luis Ernesto¹,Hidalgo Ricardo¹,Cardona Andrés Felipe²,Martí-Carvajal Arturo J³

Affiliation:

1. Universidad Tecnológica Equinoccial; Facultad de Ciencias de la Salud Eugenio Espejo; Bourgeois N34-102 y Rumipamba Quito Ecuador 17 01 2764

2. Institute of Oncology, Fundación Santa Fe de Bogotá; Clinical and Translational Oncology Group; Calle 119 No. 7 - 75 Bogotá Cundinamarca Colombia 0571

3. Iberoamerican Cochrane Network; Valencia Venezuela

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008259.pub2/fullpdf

Reference63 articles.

1. NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia;Ahuja;Genes, Chromosomes and Cancer,2001

2. Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country;Aziz;Cancer,2007

3. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

4. Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase;Bittencourt;Bone Marrow Transplantation,2008

5. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia;Cohen;Clinical Cancer Research,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP